1. Marsden CD, Schachter M (1981) Assessment of extrapyramidal disorders. Br J Clin Pharmacol 11:129–151
2. Larsen AT, LeWitt PA, Came DB (1983) Theoretical and practical issues in assessment of deficits and therapy in parkinsonism. In: Calne DB, Horowski R, McDonald RJ, Wittke W (eds) Lisuride and other dopamine agonists. Raven, New York, pp 363–373
3. Ward CD, Sanes JN, Dambriosia JM, Calne DB (1983) Methods for evaluating treatment in Parkinson’s disease. In: Fahn S, Calne DB, Shoulson I (eds) Experimental therapeutics of movement disorders. Raven, New York, pp 1–7 (Advances in neurology, vol 37)
4. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
5. Fahn S (1975) “On off” phenomenon with levodopa therapy in parkinsonism. Neurology (Minneapolis) 24:431–444